AXSOME THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
AXSOME THERAPEUTICS, INC. (AXSM) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $80.33 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-10
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $80.33M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $84.88M.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $87.55M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $99.56M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2026-06-30 | $80.33M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $84.88M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $87.55M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $99.56M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $88.89M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $99.19M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $99.97M 10-K · filed 2026-02-23 |
| 2024-09-30 | $91.11M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $76.66M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $76.39M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $79.71M 10-K · filed 2025-02-18 |
| 2023-09-30 | $38.22M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $39.84M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $35.10M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $37.00M 10-K · filed 2024-02-23 |
| 2022-09-30 | $34.40M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $35.28M 10-Q · filed 2022-08-09 |
| 2018-09-30 | $102.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $117.00K 10-Q · filed 2018-11-09 |
| 2018-03-31 | $118.00K 10-Q · filed 2018-08-08 |
| 2017-12-31 | $2.79M 10-K · filed 2019-03-15 |
| 2015-12-31 | $1.34M 10-K · filed 2018-03-07 |
| 2015-09-30 | $150.80K 10-Q · filed 2016-11-14 |
| 2015-06-30 | $1.40M 10-Q · filed 2016-11-14 |
| 2015-03-31 | $734.76K 10-Q/A · filed 2016-08-09 |
| 2014-12-31 | $632.63K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |